Krystal Biotech (KRYS) Other Operating Expenses (2023 - 2026)

Krystal Biotech has reported Other Operating Expenses for 4 years, with the latest figure at $6.4 million in Q2 2026.

• Other Operating Expenses for Q2 2026 came in at $6.4 million, down 10.16% year-over-year; the trailing twelve-month figure through Jun 2026 was $23.6 million (up 193.31% YoY), and the FY2024 annual result was -$37.5 million, down 137.5% from the prior year.
• Other Operating Expenses rose to $6.4 million in Q2 2026, from $6.3 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $100.0 million in Q3 2023 and troughed at -$37.5 million in Q4 2024.
• A 4-year average of $4.0 million and a median of $5.0 million in 2025 frame the typical range for Other Operating Expenses.
• The widest annual swing landed in 2024, when Other Operating Expenses sank 51.93%; it then jumped 137.73% in 2025.
• A 4-year view of Other Operating Expenses shows it stood at $100.0 million in 2023, then plunged by 137.5% to -$37.5 million in 2024, then jumped by 117.58% to $6.6 million in 2025, then declined by 2.35% to $6.4 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $6.4 million in Q2 2026, $6.3 million in Q1 2026, and $6.6 million in Q4 2025.